Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zika Virus Infection | 7 | 2021 | 39 | 2.250 |
Why?
|
| Zika Virus | 6 | 2021 | 38 | 1.170 |
Why?
|
| BK Virus | 4 | 2016 | 23 | 1.090 |
Why?
|
| Nicaragua | 11 | 2021 | 17 | 0.840 |
Why?
|
| Dengue | 6 | 2021 | 97 | 0.770 |
Why?
|
| Serologic Tests | 3 | 2022 | 34 | 0.740 |
Why?
|
| Antibodies, Viral | 7 | 2024 | 325 | 0.720 |
Why?
|
| Fomites | 2 | 2021 | 4 | 0.700 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 542 | 0.680 |
Why?
|
| Dengue Virus | 6 | 2021 | 100 | 0.660 |
Why?
|
| Tumor Virus Infections | 2 | 2016 | 26 | 0.590 |
Why?
|
| Chikungunya Fever | 1 | 2019 | 4 | 0.580 |
Why?
|
| Polyomavirus Infections | 2 | 2016 | 31 | 0.580 |
Why?
|
| Chikungunya virus | 1 | 2019 | 3 | 0.580 |
Why?
|
| Asymptomatic Infections | 1 | 2019 | 29 | 0.570 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 10 | 0.560 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 25 | 0.550 |
Why?
|
| Epidemiological Monitoring | 1 | 2018 | 32 | 0.540 |
Why?
|
| Virus Replication | 4 | 2021 | 323 | 0.520 |
Why?
|
| Seroepidemiologic Studies | 4 | 2023 | 51 | 0.510 |
Why?
|
| Salivary Glands | 2 | 2015 | 45 | 0.510 |
Why?
|
| Saliva | 3 | 2024 | 100 | 0.500 |
Why?
|
| Salivary Gland Diseases | 1 | 2016 | 2 | 0.480 |
Why?
|
| Pharynx | 1 | 2016 | 25 | 0.470 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 687 | 0.470 |
Why?
|
| Viral Load | 4 | 2020 | 230 | 0.450 |
Why?
|
| Child, Preschool | 9 | 2021 | 2067 | 0.440 |
Why?
|
| Child | 10 | 2021 | 4623 | 0.400 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 1172 | 0.390 |
Why?
|
| Adolescent | 10 | 2023 | 6333 | 0.380 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 449 | 0.340 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2020 | 34 | 0.340 |
Why?
|
| Epidemics | 3 | 2021 | 27 | 0.320 |
Why?
|
| Humans | 27 | 2024 | 65498 | 0.310 |
Why?
|
| Vero Cells | 3 | 2021 | 81 | 0.310 |
Why?
|
| Female | 15 | 2024 | 34216 | 0.300 |
Why?
|
| HIV Infections | 1 | 2016 | 957 | 0.290 |
Why?
|
| Male | 14 | 2024 | 31208 | 0.280 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 2725 | 0.240 |
Why?
|
| Middle Aged | 8 | 2024 | 18393 | 0.230 |
Why?
|
| Cohort Studies | 4 | 2021 | 2633 | 0.230 |
Why?
|
| Adult | 7 | 2024 | 17467 | 0.230 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2023 | 114 | 0.220 |
Why?
|
| Aerosols | 2 | 2021 | 46 | 0.200 |
Why?
|
| DNA, Viral | 2 | 2016 | 232 | 0.200 |
Why?
|
| RNA, Viral | 3 | 2022 | 266 | 0.190 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 34 | 0.190 |
Why?
|
| Virus Shedding | 2 | 2021 | 17 | 0.190 |
Why?
|
| Cross Reactions | 2 | 2021 | 140 | 0.180 |
Why?
|
| Adenovirus Infections, Human | 1 | 2021 | 3 | 0.180 |
Why?
|
| Adenoviruses, Human | 1 | 2021 | 10 | 0.170 |
Why?
|
| Aged | 4 | 2024 | 15062 | 0.170 |
Why?
|
| Coronavirus 229E, Human | 1 | 2021 | 2 | 0.170 |
Why?
|
| Air Microbiology | 1 | 2021 | 11 | 0.170 |
Why?
|
| Nasopharynx | 1 | 2020 | 21 | 0.160 |
Why?
|
| Environmental Microbiology | 1 | 2020 | 15 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 468 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2021 | 90 | 0.160 |
Why?
|
| Genome, Viral | 1 | 2021 | 145 | 0.160 |
Why?
|
| Bird Diseases | 1 | 2020 | 2 | 0.160 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2020 | 4 | 0.160 |
Why?
|
| Swine Diseases | 1 | 2020 | 4 | 0.160 |
Why?
|
| Coronavirus | 1 | 2020 | 14 | 0.160 |
Why?
|
| Feces | 1 | 2020 | 118 | 0.160 |
Why?
|
| Military Personnel | 1 | 2021 | 110 | 0.160 |
Why?
|
| beta-Lactamases | 1 | 2020 | 18 | 0.160 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 56 | 0.150 |
Why?
|
| Massachusetts | 1 | 2024 | 2153 | 0.140 |
Why?
|
| Family Characteristics | 1 | 2018 | 46 | 0.140 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 52 | 0.140 |
Why?
|
| Prospective Studies | 3 | 2020 | 3326 | 0.140 |
Why?
|
| Phylogeny | 1 | 2019 | 389 | 0.130 |
Why?
|
| Influenza A virus | 1 | 2018 | 120 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 219 | 0.130 |
Why?
|
| Antiviral Agents | 2 | 2021 | 326 | 0.130 |
Why?
|
| Genotype | 1 | 2019 | 674 | 0.120 |
Why?
|
| Infant | 2 | 2018 | 1704 | 0.120 |
Why?
|
| Body Fluids | 1 | 2016 | 21 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2018 | 210 | 0.120 |
Why?
|
| Animals | 6 | 2021 | 21394 | 0.120 |
Why?
|
| Cell Transformation, Viral | 1 | 2015 | 15 | 0.120 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2015 | 11 | 0.120 |
Why?
|
| Virus Integration | 1 | 2015 | 33 | 0.110 |
Why?
|
| Isoxazoles | 1 | 2015 | 15 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2021 | 924 | 0.110 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 24 | 0.110 |
Why?
|
| Organophosphonates | 1 | 2015 | 22 | 0.110 |
Why?
|
| Cytosine | 1 | 2015 | 31 | 0.110 |
Why?
|
| Young Adult | 3 | 2023 | 4839 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2018 | 1021 | 0.110 |
Why?
|
| Carcinoma | 1 | 2015 | 130 | 0.110 |
Why?
|
| Risk Factors | 3 | 2019 | 5462 | 0.100 |
Why?
|
| Blotting, Southern | 1 | 2013 | 56 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2013 | 111 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 806 | 0.100 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 173 | 0.100 |
Why?
|
| Genome, Human | 1 | 2015 | 237 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 139 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5650 | 0.100 |
Why?
|
| DNA Primers | 1 | 2013 | 301 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 363 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 2015 | 325 | 0.090 |
Why?
|
| Base Sequence | 1 | 2013 | 1331 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1588 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1979 | 0.080 |
Why?
|
| Obesity | 1 | 2018 | 1276 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2015 | 5 | 0.060 |
Why?
|
| Informed Consent | 1 | 2023 | 142 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2022 | 12 | 0.050 |
Why?
|
| Environmental Pollution | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cell Degranulation | 1 | 2022 | 23 | 0.050 |
Why?
|
| Aedes | 1 | 2021 | 14 | 0.040 |
Why?
|
| Mosquito Vectors | 1 | 2021 | 17 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 39 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 110 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2021 | 56 | 0.040 |
Why?
|
| China | 1 | 2021 | 177 | 0.040 |
Why?
|
| Birds | 1 | 2020 | 10 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2022 | 663 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 177 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 217 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 129 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 397 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 3774 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2020 | 60 | 0.040 |
Why?
|
| Swine | 1 | 2020 | 397 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 146 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 27 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 180 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 211 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2020 | 395 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 2024 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 887 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 47 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 49 | 0.030 |
Why?
|
| Urothelium | 1 | 2015 | 22 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 995 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 687 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 254 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1565 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 59 | 0.030 |
Why?
|
| Capsid Proteins | 1 | 2015 | 107 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 1431 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 460 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 586 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 6939 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1039 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2015 | 718 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2188 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1577 | 0.020 |
Why?
|
| United States | 1 | 2021 | 8149 | 0.020 |
Why?
|